Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Refined by:
x 2021
Clear All
21 - 40 of 82 Results
View:
Sort By:
Refine Results
All Collections
Small Close Icon

Sort By

Refine Results:
All Collections
Small Close Icon
Next ›
Narrow Results:
Publish Year
  • x
    202182
Genre
More
Document Type
More
Subject
More
Name as Subject
More
Place as Subject
More
  • Why are Rates of Reported Chlamydia Changing in the United States?: Insights from the National Job Training Program
    Coming Soon
    Personal Author:
    Diesel, Jill ; Kreisel, Kristen ; ...
    Published Date:
    2021
    Source:
    Sex Transm Dis. 48(3):152-160
    Description:
    Background:During 2010–2017, rates of reported chlamydia decreased among young Black women but increased for White women and all men. Since chlamydi...
    Public Access
    Available on:
    March 01, 2022
    File Type:
    Filetype[PDF - 999.42 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : California
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $6,851,675Publication date from document properties.1 local CDC fellowOne of 10 sites for the Emerging Inf...
    File Type:
    Filetype[PDF - 575.27 KB]
    File Type:
    Filetype[PDF - 575.27 KB]
  • Estimating the Direct Medical Costs and Productivity Loss of Outpatient Chlamydia and Gonorrhea Treatment
    Coming Soon
    Personal Author:
    Kumar, Sagar ; Chesson, Harrell ; ...
    Published Date:
    Feb 01 2021
    Source:
    Sex Transm Dis. 48(2):e18-e21
    Description:
    We used 2016-2017 administrative claims data to calculate the direct medical cost and productivity loss per diagnosed case of chlamydia and gonorrhea ...
    Public Access
    Available on:
    February 01, 2022
    File Type:
    Filetype[PDF - 67.22 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Maryland
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $10,203,5521 local CDC AR expert & 1 local CDC fellowRegional Lab for the AR Lab Network (Mid-Atlantic)One...
    File Type:
    Filetype[PDF - 686.37 KB]
    File Type:
    Filetype[PDF - 686.37 KB]
  • NMI notes ; February 2021
    Corporate Authors:
    Council of State and Territorial Epidemiologists.
    Published Date:
    February 2021
    Series:
    NMI notes ; February 2021
    File Type:
    Filetype[PDF - 324.22 KB]
    File Type:
    Filetype[PDF - 324.22 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Louisiana
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Source:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020; AR solutions in action;
    Description:
    Funding for AR Activities Fiscal Year 2020: $547,172Publication date from document properties.Louisiana-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 325.10 KB]
    File Type:
    Filetype[PDF - 325.10 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Arizona
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $830,973Publication date from document properties.Arizona-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 325.42 KB]
    File Type:
    Filetype[PDF - 325.42 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Delaware
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $406,112Publication date from document properties.Delaware-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 324.05 KB]
    File Type:
    Filetype[PDF - 324.05 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Alabama
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Description:
    Funding for AR Activities Fiscal Year 2020: $535,015Publication date from document properties.Alabama-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 324.75 KB]
    File Type:
    Filetype[PDF - 324.75 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Alaska
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $332,207Publication date from document properties.Alaska-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 325.66 KB]
    File Type:
    Filetype[PDF - 325.66 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Mississippi
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $520,423Publication date from document properties.Mississippi-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 341.95 KB]
    File Type:
    Filetype[PDF - 341.95 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Nevada
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $687,384Publication date from document properties.
    File Type:
    Filetype[PDF - 325.58 KB]
    File Type:
    Filetype[PDF - 325.58 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Mississippi
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $520,423Publication date from document properties.Mississippi-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 341.95 KB]
    File Type:
    Filetype[PDF - 341.95 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Texas
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $1,967,7401 local CDC fellowPublication date from document properties.Texas-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 370.47 KB]
    File Type:
    Filetype[PDF - 370.47 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Missouri
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $1,823,764CDC Prevention EpicenterPublication date from document properties.Missouri-CDC-AR-Investments.pd...
    File Type:
    Filetype[PDF - 484.95 KB]
    File Type:
    Filetype[PDF - 484.95 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Michigan
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $5,168,8841 local CDC fellowAR Lab Network’s National Tuberculosis Molecular Surveillance CenterPublicat...
    File Type:
    Filetype[PDF - 412.01 KB]
    File Type:
    Filetype[PDF - 412.01 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Minnesota
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $7,146,9012 local CDC fellowsRegional Lab for the AR Lab Network (Central)One of 10 sites for the Emerging...
    File Type:
    Filetype[PDF - 527.50 KB]
    File Type:
    Filetype[PDF - 527.50 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : District of Columbia
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $3,425,918Publication date from document properties.District-of-Columbia-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 734.97 KB]
    File Type:
    Filetype[PDF - 734.97 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Illinois
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $4,107,4491 local CDC fellowCDC Prevention EpicenterPublication date from document properties.Illinois-CDC...
    File Type:
    Filetype[PDF - 635.59 KB]
    File Type:
    Filetype[PDF - 635.59 KB]
  • CDC’s investments to combat antibiotic resistance threats nationwide : Chicago, IL
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
    Published Date:
    1/24/2021
    Series:
    CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide ; fiscal year 2020
    AR solutions in action
    Description:
    Funding for AR Activities Fiscal Year 2020: $2,852,180CDC Prevention EpicenterPublication date from document properties.Chicago-CDC-AR-Investments.pdf
    File Type:
    Filetype[PDF - 580.09 KB]
    File Type:
    Filetype[PDF - 580.09 KB]
21 - 40 / 82
Sort By:
Refine Results:
All Collections
Small Close Icon
‹ PreviousNext ›